Cancer Genetics (CGIX) Tops Q3 EPS by 5c

November 10, 2016 7:20 AM EST
Get Alerts CGIX Hot Sheet
Trade CGIX Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Cancer Genetics (NASDAQ: CGIX) reported Q3 EPS of ($0.23), $0.05 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $6.93 million.

For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment